Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.07

+0.9%

Nov 12 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2546)	8/3/2009 12:53:32 PM
From: Jibacoa	Read Replies (1) of 3722

ONTY is up 27% with volume about 8x its ADV.<g> The stock continued its recent UT as it opened with a good UG bigcharts.marketwatch.com It announced that clinical data relating to long-term treatment with Stimuvax were presented at the International Association for the Study of Lung Cancer's 13th World Conference on Lung Cancer in Frisco on Aug 1. The presentation involved 16 patients who received treatment with Stimuvax for between 2 and 8.2 years as part of the PIIb in patients with stage IIIb/IV NSCLC.Ten of the 16 studied patients were alive without evidence of disease progression, of whom 8 continued to receive therapy with Stimuvax after 6.3 to 8.2 years. The remaining 2 living patients discontinued Stimuvax therapy after 2.4 and 5.8 years, respectively, and were without evidence of disease progression. Nine of the 10 living patients had stage IIIb NSCLC upon entry to the trial, while one had stage IV disease. Six of the 10 living patients had a complete response to their first-line chemotherapy or chemo-radiation, while four patients had stable disease. The remaining 6 of the 16 patients discontinued Stimuvax after 2.0 to 5.1 years of treatment as a result of disease progression and are deceased. With some further good news, it seems that the stock still has plenty of room to run.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next